Inventurus Knowledge Solutions has submitted the transcript of its conference call held on April 24, 2026, to BSE Limited and National Stock Exchange of India Limited. The call discussed the company's agreement to acquire TruBridge Inc., a prominent healthcare technology provider for rural and community hospitals, in a USD 565 million transaction.

Regulatory Compliance and Documentation

The company filed the conference call transcript under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary Sameer Chavan confirmed the submission on April 29, 2026, noting that the transcript has also been uploaded to the company's website.

Strategic Acquisition Overview

During the conference call, Founder and CEO Sachin Gupta outlined the strategic rationale for acquiring TruBridge, emphasizing the creation of an integrated system of record and platform system of action. The acquisition targets the rural healthcare market, which serves 20% of America's population across 2,200 rural hospitals generating USD 164 billion in revenue.

TruBridge Business Metrics

TruBridge operates as the leading system of record for rural healthcare, serving approximately 700 hospitals with a 40% market share in the 0-50 bed hospital segment. The company's financial performance shows strong positioning in the niche market.

Integration and Growth Strategy

The management outlined a comprehensive integration timeline spanning four to five quarters post-closing. The combined entity expects to achieve significant synergies through operational efficiencies, technology modernization, and global delivery model optimization.

Financial Projections and Market Opportunity

Gupta presented a four-year vision targeting INR 3,000 crores EBITDA by FY30, representing substantial growth from the current INR 1,000 crores baseline. The rural healthcare RCM market presents a USD 3.5-4 billion total addressable market opportunity.

Postal Ballot Process

The acquisition requires shareholder approval through postal ballot, with e-voting scheduled from April 30 to May 29, 2026. The company previously dispatched postal ballot notices on April 28, 2026, seeking approval for two special resolutions related to the TruBridge acquisition financing and subsidiary guarantees.

The transaction is expected to close during the third calendar quarter of 2026, subject to regulatory approvals including HSR clearance from the Federal Trade Commission and successful completion of the postal ballot process.

Inventurus Knowledge Solutions Limited's Nomination and Remuneration Committee has approved the grant of 12,700 employee stock options to eligible employees under the IKS ESOP Plan on April 28, 2026. The approval was granted pursuant to the provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

ESOP Grant Details

The employee stock options are being granted under the company's ESOP Plan 2022, which is administered through a trust. Each option granted is convertible into one fully paid-up equity share with a face value of Re. 1. The options are being granted at an exercise price of Rs. 1,505.20 per option, which is not less than the market price—the closing price on April 27, 2026, on BSE Limited being the trading day immediately preceding the date of the committee's approval.

Key ESOP Parameters

Vesting and Exercise Framework

The stock options granted shall be capable of being exercised anytime during the entire period of continuous active employment from the date of vesting of the respective options. The scheme provides comprehensive guidelines for handling stock options in various scenarios including death, permanent incapacity, resignation, termination, and retirement of employees.

Corporate Action Provisions

In case of corporate actions such as rights issue, bonus issue, split or consolidation of equity shares, merger, amalgamation, or sale of division, requisite adjustments shall be appropriately made in accordance with the IKS ESOP Plan. The equity shares allotted pursuant to the exercise of the stock options would not be subject to lock-in restrictions.

Regulatory Compliance

The disclosure has been made to both BSE Limited and National Stock Exchange of India Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Sameer Chavan signed the regulatory filing on April 28, 2026.